Evidence map›Paper›PMID 39138400›Full record

ArticleBMC infectious diseases2024

Antibiotic prescribing practices and antibiotic use quality indicators in Luang Prabang, Lao PDR: a point prevalence survey in a tertiary care hospital.

Christelle Elias, Nay Thi Ha, Onanong Sengvilaipaserth, Athip Phaychith, Vilada Chansamouth, Valy Phongsavath, Bounxou Keohavong, Khamsay Detleuxay, Phaylinh Maniphonh, Thongphout Soukhaseum and 2 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christelle EliasService d'Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France. christelle.elias@chu-lyon.fr.
Nay Thi HaFondation Mérieux, South-East Asia Regional Office, Vientiane, Laos. nay.thiha@fondation-merieux.org.
Onanong SengvilaipaserthFondation Mérieux, South-East Asia Regional Office, Vientiane, Laos.
Athip PhaychithFondation Mérieux, South-East Asia Regional Office, Vientiane, Laos.
Vilada ChansamouthMicrobiology Laboratory, Mahosot Hospital, Vientiane, Laos.
Valy PhongsavathLuang Prabang Hospital, Luang Prabang, Laos.
Bounxou KeohavongFood and Drug Administration, Vientiane, Laos.
Khamsay DetleuxayDepartment of Healthcare and Rehabilitation, Ministry of Health, Vientiane, Laos.
Phaylinh ManiphonhLuang Prabang Hospital, Luang Prabang, Laos.
Thongphout SoukhaseumLuang Prabang Hospital, Luang Prabang, Laos.
Philippe VanhemsService d'Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France.
François-Xavier BabinFondation Mérieux, Lyon, France.

Funding

Fleming Fund Country Grant 2 FF86-492
6 · The paper itself

Abstract

contextThe increase and global dissemination of antibiotic resistance limit the use of antibiotics to prevent and treat infections. Implementing antibiotic stewardship programs guided by local data on prescription profiles is a useful strategy to reduce the burden of antibiotic resistance. The aim was to determine the prevalence of antibiotic use and guideline compliance at Luang Prabang provincial hospital, Lao PDR.

methodsA point prevalence survey of antibiotics was conducted among hospitalized patients admitted to Luang Prabang hospital (204 beds) in Lao PDR on May 25, 2023. All patients presenting at 8:00 AM were eligible. Sociodemographic data, indications for antibiotic use, and antibiotic prescriptions were collected from medical records using a paper-based questionnaire and entered into an electronic platform following WHO methodology. The prevalence of antibiotic use was determined.

resultsOut of the 102 patients included, 60(58.8%) were undergoing antibiotic treatment, of which 33(55.0%) received combination therapy, and 7(10.5%) had two indications for antibiotic use. The highest prevalence was in the surgical ward (14/15, 93%) followed by general paediatrics (18/27, 67%). Out of the 100 antibiotic prescriptions, 47(47%) were for community-acquired infections, 26(26%) for surgical prophylaxis, 13(13%) for hospital-acquired infections and 5(5%) for medical prophylaxis. Twenty(20%) antibiotics were prescribed for obstetrics and gynaecology prophylaxis, 17(17%) for intra-abdominal infections, and 10(10.0%) for pneumonia treatment as well as bone, and joint infections. The main antibiotics prescribed were ceftriaxone 36(34.6%), metronidazole 18(17.3%), ampicillin 8(7.7%), and gentamicin 8(7.7%). Only 2(3%) samples were sent to the laboratory, one of which showed a positive culture for Escherichia coli Extended Spectrum β-Lactamase. According to the WHO Access Watch and Reserve classification, 55(52.9%) molecules belonged to the Access category, 47(49.1%) to the Watch category, and none to the Reserve category. Only 14.9% of antibiotic prescriptions were fully compliant with current guidelines.

conclusionThis study indicated a significant prevalence of antibiotic use and a very low compliance with guidelines at Luang Prabang provincial hospital, Lao PDR. This highlights an urgent need for comprehensive strategies at all levels to optimize antibiotic use in hospitals, emphasizing diagnostic improvements, and continued research to address the factors driving this excessive antibiotic usage and improve adherence to guidelines.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipGuideline AdherencePractice Patterns, Physicians'Tertiary Care CentersAdolescentAdultAgedChildChild, PreschoolCross-Sectional StudiesDrug PrescriptionsFemaleHumansInfantLaosAnti-Bacterial AgentsAntibioticAntibiotic resistanceAntibiotic stewardshipGuidelinesLMICs

Identifiers

PMID39138400
PMCPMC11321149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.